Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 10Leukemia 8Congenital Abnormalities 8Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelomonocytic, Chronic 5Myeloproliferative Disorders 4Leukemia, Myeloid, Chronic-Phase 4Thrombocythemia, Essential 3Polycythemia Vera 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Primary Myelofibrosis 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Chromosome 5q Deletion Syndrome 2Burkitt Lymphoma 2

Interventions

Cyclophosphamide 17Peripheral Blood Stem Cell Transplantation 16fludarabine phosphate 15Busulfan 15Tacrolimus 13Methotrexate 13Mycophenolic Acid 11Cyclosporine 11Antilymphocyte Serum 11Whole-Body Irradiation 9Flow Cytometry 8Radiotherapy 6Methylprednisolone 6Melphalan 6Filgrastim 6Etoposide 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Sirolimus 4Polymerase Chain Reaction 4Immunoenzyme Techniques 4thymoglobulin 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cyclosporins 3Aprepitant 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pdgfra-Associated Chronic Eosinophilic Leukemia × Cytogenetic Analysis × Clear all
NCT00816413 2023-08-14

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

University of Nebraska

Phase 1/2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Blast Crisis, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡